Should RAAS blockade therapy be continued in patients with advanced renal disease?
{{output}}
Probably. Renin-angiotensin-aldosterone system (RAAS) blockade therapy should be continued in most patients with advanced renal disease and comorbid conditions; however, individualized treatment is warranted as data on the benefits and harms in all-cause morta... ...
